Glaxo SmithKline Consumer Nigeria Plc posts a profit of N622.2 million in FY 2020.

Glaxo SmithKline Consumer Nigeria Plc released its full-year results for the year ended 31st December 2020.

  • Revenue for the year was N21.3 billion. (+2.6% YoY)
  • Cost of sales was N15.4 billion. (+4.6% YoY)
  • Administrative expenses totaled N1.59 billion. (-17.6% YoY)
  • Profit after tax was N622.2 million. (-32.2% YoY)
  • Earnings per share of 52 kobo vs 77 kobo YoY.
  • A dividend of 40 kobo was proposed.

See link to results.

Leave a Reply

Your email address will not be published. Required fields are marked *